Federal Pre-Emption Under The Food, Drug & Cosmetic Act From Medtronic, Inc. V. Lohr; Pliva, Inc. V. Mensing



Beginning in 1996, the United States Supreme Court took a series of cases related to Federal preemption of state law claims for products approved by the United States Food and Drug Administration (''FDA''). In some instances, these courts found federal law pre-empted state law claims. In other cases, the court found that no federal pre emption existed and allowed the state law claims to proceed. This article examines the reasoning in each of these five cases as well as two state court cases related to federal pre-emption. In doing so, this article describes the current landscape of federal pre-emption for products approved by the FDA.

Federal Pre-Emption The theory of federal pre-emption rests on the Supremacy Clause of the United States Constitution. The Supremacy Clause provides that federal law is ''the supreme law of the land; ... anything in the constitution or laws of any state to the contrary notwithstanding.'' Therefore, a state law that conflicts with federal law is pre-empted and has no effect.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Published In: Administrative Agency Updates, Conflict of Laws Updates, Constitutional Law Updates, Products Liability Updates

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Duane Morris LLP | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »